Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole augmentation of sertraline in adolescents with obsessive-compulsive disorder
IRCT20190104042227N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Sertraline + placebo with Sertraline + aripiprazole (2 arms). Primary endpoints: Study of therapeutic effects and Yale-Brown scale assessment at weeks 4, 8, and 12. Started Aug 2018; status: completed.
02
Drugs
aripiprazolesertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20190104042227N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190104042227N1.